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Lower levels of serum bicarbonate and a higher anion
gap have been associated with insulin resistance and
hypertension in the general population. Whether these
associations extend to other cardiovascular disease risk
factors is unknown. To clarify this, we examined the
association of serum bicarbonate and anion gap with
cardiorespiratory fitness in 2714 adults aged 20–49 years in
the 1999–2004 National Health and Nutrition Examination
Survey. The mean serum bicarbonate was 24.6mEq/l and the
mean anion gap was 10.26mEq/l, with fitness determined by
submaximal exercise testing. After multivariable adjustment,
gender, length of fasting, soft drink consumption, systolic
blood pressure, serum phosphate, and hemoglobin were
independently associated with both the serum bicarbonate
and the anion gap. Low fitness was most prevalent among
those in the lowest quartile of serum bicarbonate or highest
quartile of anion gap. After multivariable adjustment, a 1 s.d.
higher serum bicarbonate or anion gap was associated with
an odds ratio for low fitness of 0.80 (95% CI 0.70–0.91) and
1.30 (95% CI 1.15–1.48), respectively. The association of
bicarbonate with fitness may be mediated by differences
in lean body mass. Thus, lower levels of serum bicarbonate
and higher levels of anion gap are associated with lower
cardiorespiratory fitness in adults aged 20–49 years in the
general population.
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Chronic metabolic acidosis as a manifestation of chronic
kidney disease is believed to adversely affect skeletal muscle
protein breakdown.1 Chronic acidosis may have other
sequelae, including contributing to insulin resistance2 and
the progression of kidney disease.3,4 These effects may extend
to the non-chronic kidney disease population. A low-level
chronic acidosis, partly due to aging and the acidogenic
Western diet, has been associated with pathophysiologic
consequences in older persons without chronic kidney
disease, including urinary nitrogen wasting5 and reduced
muscle strength.6,7
Cross-sectional studies of healthy persons have demonstrated
an association of lower levels of serum bicarbonate and higher
levels of anion gap (AG) with greater insulin resistance and
higher blood pressure.8–10 Whether these associations extend to
other cardiovascular disease (CVD) risk factors is unknown.
Low cardiorespiratory fitness, or aerobic capacity, is associated
with an increased prevalence of CVD risk factors11 and with
mortality and incident CVD.12,13 Reduced muscle mass or
function because of metabolic acidosis could reduce skeletal
muscle oxygen uptake, and thus cardiorespiratory fitness.
We hypothesized that lower levels of serum bicarbonate
and higher levels of AG would be associated with lower
cardiorespiratory fitness in the general population. We tested
these hypotheses in adult participants aged 20–49 years who
completed submaximal exercise testing in the National Health
and Nutrition Examination Survey (NHANES) 1999–2004.
RESULTS
Participant characteristics
The mean serum bicarbonate was 24.6 mEq/l (s.e. 0.1) and
the mean AG was 10.26 mEq/l (s.e. 0.18). Participants with
lower serum bicarbonate were more likely to be women, had
higher body mass index (BMI), greater poverty, and higher
estimated net endogenous acid production (NEAP), were
less likely to have fasted 2 h or less before phlebotomy, were
more likely to report consuming soft drinks and to have
hypertension, and had higher levels of AG and C-reactive
protein (CRP) and lower serum albumin, calcium, and
hemoglobin, and lower % lean body mass (%LBM) (Table 1).
Participants with higher levels of AG had higher BMI, greater
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poverty, were more likely to report soft drink consumption
and to have hypertension and diabetes, had higher systolic
blood pressure, were more likely to have albuminuria, and
had lower serum bicarbonate and higher hemoglobin, total
cholesterol, and CRP levels, and lower %LBM (Table 2). No
participants had CVD by self-report.
After multivariable adjustment, sex, fasting length, soft
drink consumption, systolic blood pressure, serum phosphate,
and hemoglobin were independently associated with both
serum bicarbonate and AG (Table 3). For each, the direction of
association differed for serum bicarbonate and AG, respec-
tively. In addition, age, diuretic use, and serum sodium and
chloride levels were significantly associated with bicarbonate
level, and total cholesterol and CRP were significantly
associated with AG. Multivariable models were also examined
entering sugar-sweetened and diet soft drink consumption
simultaneously into the model. Of 1371 participants reporting
consumption ofX1 soft drink, 351 (25.6%) reported only diet
soft drink consumption. Sugar-sweetened soft drink con-
sumption (X1 vs. 0) was associated with a 0.36 mEq/l (95%
Table 1 | Participant characteristics by quartiles of serum bicarbonate
Serum bicarbonate (mEq/l)
Characteristic o24 24–25 25.1–26.9 27 P-value
Number 833 661 747 473
Age (years) 33.8 (0.4) 33.7 (0.5) 34.3 (0.4) 34.2 (0.6) 0.43
Women (%) 60.8 (3.2) 50.0 (2.8) 40.1 (2.0) 26.6 (2.6) o0.001
Race/ethnicity (%) 0.14
Non-Hispanic White 70.8 (2.2) 73.0 (2.3) 69.9 (2.5) 76.4 (2.0)
Mexican American 11.3 (2.3) 9.4 (1.2) 10.5 (1.3) 5.4 (0.9)
Non-Hispanic Black 8.2 (1.3) 10.2 (1.7) 11.1 (1.3) 10.5 (1.5)
Body mass index (kg/m2) 28.2 (0.3) 27.0 (0.3) 26.7 (0.2) 25.5 (0.2) o0.001
% Lean body mass 62.5 (0.3) 65.0 (0.4) 66.7 (0.4) 69.1 (0.5) o0.001
Poverty (o100% poverty index, %) 12.8 (1.6) 12.3 (1.9) 11.0 (1.4) 7.2 (1.5) 0.01
Less than high-school diploma (%) 12.1 (1.3) 13.5 (1.5) 14.6 (1.6) 11.0 (2.3) 0.97
Activity level (MET-min/week, %) 0.08
0 9.5 (1.1) 8.5 (1.1) 12.0 (1.6) 6.8 (1.4)
o500 22.9 (2.1) 19.7 (1.8) 17.7 (1.7) 17.6 (2.2)
500–2000 35.1 (1.9) 37.9 (3.2) 38.8 (2.1) 35.6 (2.0)
42000 32.5 (2.6) 33.8 (2.6) 31.5 (2.3) 40.0 (2.8)
Smoking (%) 0.24
Never 55.0 (3.1) 55.0 (2.4) 58.4(2.3) 61.6 (2.9)
Former 15.4 (1.7) 17.4 (2.0) 15.5 (1.4) 17.2 (1.7)
Current 29.6 (2.6) 27.6 (2.0) 25.9 (2.3) 21.3 (2.4)
Estimated NEAP (mEq/day) 60.4 (1.2) 62.9 (1.0) 59.8 (1.2) 55.1 (1.1) 0.005
Fasting length p2h (%) 1.4 (0.4) 2.5 (0.8) 2.7 (0.5) 4.4 (1.9) 0.04
Soft drink consumption (%) 0.003
None 45.6 (3.2) 56.7 (3.2) 43.9 (2.6) 55.9 (3.6)
1 31.9 (2.9) 23.2 (3.0) 27.9 (1.9) 27.7 (2.8)
X2 22.5 (1.9) 20.1 (2.4) 28.2 (1.8) 16.5 (2.7)
Diuretic use (%) 0.9 (0.5) 1.0 (0.4) 2.3 (0.9) 1.4 (0.6) 0.23
Cholesterol-lowering medication (%) 1.4 (0.5) 2.2 (0.9) 2.6 (0.8) 1.7 (0.9) 0.59
Hypertension (%) 19.8 (1.9) 9.6 (1.5) 13.6 (1.7) 10.9 (1.9) 0.002
Diabetes mellitus (%) 1.7 (0.6) 0.9 (0.4) 1.5 (0.6) 1.2 (0.6) 0.64
Systolic blood pressure (mm Hg) 115.5 (0.6) 115.0 (0.7) 114.7 (0.7) 115.3 (0.7) 0.60
eGFR (ml/min per 1.73m2) 103.3 (1.0) 102.6 (0.9) 102.8 (0.8) 102.8 (1.2) 0.73
UACR 4 30mg/g (%) 4.9 (0.8) 5.5 (1.2) 3.4 (1.0) 2.9 (1.2) 0.13
Serum anion gap (mEq/l) 11.6 (0.3) 10.4 (0.2) 9.7 (0.2) 8.5 (0.2) o0.001
Serum albumin (g/dl) 4.37 (0.01) 4.43 (0.02) 4.46 (0.02) 4.56 (0.03) o0.001
Serum calcium (mg/dl) 9.41 (0.02) 9.52 (0.02) 9.51 (0.02) 9.54 (0.04) 0.001
Serum phosphate (mg/dl) 3.71 (0.03) 3.75 (0.03) 3.67 (0.03) 3.70 (0.03) 0.44
Hemoglobin (g/dl) 14.48 (0.11) 14.60 (0.10) 14.66 (0.07) 14.94 (0.08) 0.005
Total cholesterol (mg/dl) 191.3 (1.6) 191.5 (1.8) 193.2 (2.3) 193.6 (2.6) 0.38
HDL cholesterol (mg/dl) 50.1 (0.8) 52.5 (0.8) 50.7 (0.7) 52.4 (1.0) 0.16
C-reactive protein 1.0mg/dl (%) 7.8 (0.9) 5.8 (0.9) 4.9 (1.0) 5.2 (1.2) 0.04
Abbreviations: eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; MET, metabolic equivalent; NEAP, net endogenous acid production; UACR, urinary
albumin–creatinine ratio.
Data are expressed as mean (standard error (s.e.)) or percent (s.e.).
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confidence interval (CI) 0.03 to 0.70) lower serum bicarbonate
and 0.68 mEq/l (95% CI 0.18 to 1.19) higher AG. Diet soft
drink consumption (X1 vs. 0) was associated with a
0.19 mEq/l (95% CI 0.07 to 0.46) lower serum bicarbonate
and 0.24 mEq/l (95% CI 0.06 to 0.55) higher AG.
Association of serum bicarbonate and AG with
cardiorespiratory fitness
Figure 1 shows the prevalence of cardiorespiratory fitness
level by quartiles of serum bicarbonate and AG. Low fitness,
based on age- and sex-specific cut points, was present among
451 participants and was most prevalent among those in the
lowest quartile of serum bicarbonate or highest quartile of
AG (18.9% (95% CI 15.6–22.2) and 20.7% (95% CI
16.8–24.6), respectively).
In unadjusted analysis, a 1 s.d. higher serum bicar-
bonate was associated with a 1.46 ml/kg/min (95% CI
1.00–1.93) greater estimated maximal oxygen consumption
(VO2max), whereas a 1 s.d. higher AG was associated with a
1.07 ml/kg/min (95% CI 0.58–1.56) lower estimated VO2max
Table 2 | Participant characteristics by quartiles of serum anion gap
Serum anion gap (mEq/l)
Characteristic o8.60 8.60–10.25 10.26–11.90 X11.91 P-value
Number 653 735 691 635
Age (years) 34.7 (0.5) 33.6 (0.5) 33.8 (0.4) 33.8 (0.4) 0.26
Women (%) 42.5 (2.0) 47.8 (2.5) 48.3 (3.4) 47.0 (2.3) 0.18
Race/ethnicity (%) 0.46
Non-Hispanic White 75.4 (2.4) 68.8 (2.6) 73.6 (2.2) 71.0 (2.8)
Mexican American 8.9 (1.3) 10.2 (1.5) 9.2 (1.4) 9.8 (2.1)
Non-Hispanic Black 9.5 (1.3) 11.5 (1.5) 9.4 (1.3) 9.0 (1.9)
Body mass index (kg/m2) 26.4 (0.3) 26.9 (0.2) 27.1 (0.3) 27.8 (0.4) 0.001
% Lean body mass 66.6 (0.4) 65.3 (0.4) 65.2 (0.4) 64.5 (0.4) o0.001
Poverty (o100% poverty index, %) 7.3 (1.2) 12.6 (1.5) 11.9 (1.4) 12.9 (2.2) 0.05
Less than high-school diploma (%) 12.0 (2.3) 13.4 (1.4) 14.5 (1.4) 11.5 (1.6) 0.98
Activity level (MET-min/week, %) 0.58
0 7.2 (1.0) 10.2 (1.4) 11.9 (1.6) 8.2 (1.2)
o500 20.1 (2.5) 20.8 (2.0) 19.0 (2.2) 19.2 (2.6)
500–2000 37.1 (2.5) 36.8 (2.8) 37.2 (2.5) 36.1 (2.7)
42000 35.6 (2.0) 32.2 (2.5) 31.9 (1.8) 36.6 (3.4)
Smoking (%) 0.16
Never 61.9 (2.7) 54.7 (2.2) 56.7 (2.7) 55.2 (4.1)
Former 17.3 (1.7) 17.5 (1.7) 14.2 (1.7) 16.0 (2.0)
Current 20.8 (2.4) 27.8 (1.6) 29.1 (2.4) 28.8 (3.2)
Estimated NEAP (mEq/day) 58.7 (1.3) 59.0 (1.3) 60.5 (1.3) 61.3 (1.4) 0.16
Fasting length p2h (%) 3.4 (1.2) 3.1 (0.9) 1.5 (0.5) 2.3 (0.7) 0.21
Soft drink consumption (%) 0.004
None 55.6 (3.6) 56.6 (3.3) 44.8 (3.1) 41.7 (3.6)
1 26.4 (2.8) 25.2 (2.8) 28.7 (2.4) 31.7 (2.7)
X2 17.9 (2.0) 18.2 (2.3) 26.5 (2.2) 26.6 (2.8)
Diuretic use (%) 1.0 (0.4) 1.4 (0.8) 1.4 (0.6) 1.7 (0.7) 0.36
Cholesterol-lowering medication (%) 2.2 (0.9) 2.1 (0.7) 2.0 (0.6) 1.6 (0.6) 0.58
Hypertension (%) 10.0 (1.3) 13.4 (1.9) 16.1 (1.8) 16.8 (2.3) 0.003
Diabetes mellitus (%) 0.2 (0.1) 1.5 (0.6) 1.1 (0.2) 2.6 (0.8) 0.005
Systolic blood pressure (mm Hg) 113.3 (0.6) 114.8 (0.7) 116.0 (0.6) 116.5 (0.8) 0.001
eGFR (ml/min per 1.73m2) 103.1 (1.1) 103.8 (0.9) 101.9 (0.8) 102.8 (1.0) 0.51
UACR 4 30mg/g (%) 2.9 (0.8) 3.6 (0.8) 5.9 (1.2) 4.9 (1.2) 0.05
Serum bicarbonate (mEq/l) 26.1 (0.2) 24.9 (0.1) 24.1 (0.2) 23.3 (0.2) o0.001
Serum albumin (g/dl) 4.48 (0.02) 4.43 (0.02) 4.43 (0.02) 4.44 (0.02) 0.40
Serum calcium (mg/dl) 9.47 (0.03) 9.49 (0.02) 9.49 (0.02) 9.50 (0.04) 0.47
Serum phosphate (mg/dl) 3.65 (0.03) 3.72 (0.03) 3.68 (0.03) 3.79 (0.03) 0.01
Hemoglobin (g/dl) 14.55 (0.09) 14.50 (0.08) 14.71 (0.09) 14.81 (0.09) 0.008
Total cholesterol (mg/dl) 187.9 (1.5) 190.4 (2.0) 193.6 (2.1) 197.5 (2.6) 0.003
HDL cholesterol (mg/dl) 51.6 (0.6) 52.3 (0.7) 51.4 (0.9) 49.6 (0.8) 0.09
C-reactive protein 1.0mg/dl (%) 3.2 (1.0) 5.3 (1.2) 6.9 (0.9) 9.0 (1.6) 0.001
Abbreviations: eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; MET, metabolic equivalent; NEAP, net endogenous acid production; UACR, urinary
albumin–creatinine ratio.
Data are expressed as mean (standard error (s.e.)) or percent (s.e.).
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(Table 4, upper panel). Multivariable adjustment somewhat
attenuated these associations. Modeling serum bicarbonate
and AG as quartiles confirmed significant linear associations
of each predictor variable with estimated VO2max (Table 4,
upper panel).
Serum bicarbonate and AG were associated in opposite
directions with low fitness in univariate analysis (Table 4,
lower panel). These associations were largely unchanged after
multivariable adjustment. Compared with participants in the
lowest quartile of serum bicarbonate, there was a uniform
decreased likelihood of low fitness among participants with
bicarbonate X24 mEq/l in the fully adjusted model (odds
ratio 0.62 (95% CI 0.39–0.98), 0.69 (95% CI 0.44–1.07), and
0.64 (95% CI 0.37–1.09) for serum bicarbonate 24–25,
Table 3 | Independent predictors of serum bicarbonate and anion gap
Serum bicarbonate Anion gap
Characteristic Change (mEq/l) P-value Change (mEq/l) P-value
Age (per 10 years) 0.14 (0.01 to 0.26) 0.03 0.17 (0.35 to 0.01) 0.06
Women 1.28 (1.61 to 0.95) o0.001 0.76 (0.33 to 1.19) 0.001
Race/ethnicity
Mexican American 0.31 (0.72 to 0.10) 0.13 0.11 (0.43 to 0.64) 0.69
Non-Hispanic Black 0.10 (0.28 to 0.48) 0.60 0.10 (0.41 to 0.61) 0.69
Other 0.27 (0.72 to 0.17) 0.22 0.39 (0.13 to 0.91) 0.14
Body mass index (per 1 kg/m2) 0.03 (0.05 to 0.01) 0.003 0.003 (0.02 to 0.03) 0.83
Poverty (o100% poverty index) 0.14 (0.48 to 0.20) 0.41 0.20 (0.22 to 0.63) 0.34
Less than high-school diploma 0.23 (0.55 to 0.10) 0.17 0.21 (0.17 to 0.60) 0.27
Activity level (MET-min/week)
o500 0.13 (0.48 to 0.21) 0.44 0.07 (0.53 to 0.39) 0.76
500–2000 0.17 (0.43 to 0.09) 0.20 0.11 (0.23 to 0.46) 0.52
42000 0.25 (0.53 to 0.04) 0.09 0.25 (0.10 to 0.61) 0.16
Smoking
Former 0.11 (0.33 to 0.12) 0.35 0.11 (0.20 to 0.42) 0.48
Current 0.44 (0.75 to 0.14) 0.006 0.24 (0.11 to 0.60) 0.17
Estimated NEAP (per 10 mEq/day) 0.04 (0.08 to 0.01) 0.08 0.02 (0.03 to 0.07) 0.48
Fasting length
2–6 h 0.61 (1.37 to 0.16) 0.12 0.76 (0.06 to 1.57) 0.07
46 h 0.69 (1.32 to 0.06) 0.03 0.67 (0.13 to 1.20) 0.02
Soft drink consumption
1 0.26 (0.57 to 0.05) 0.10 0.48 (0.06 to 0.90) 0.03
X2 0.30 (0.58 to 0.02) 0.04 0.60 (0.17 to 1.04) 0.008
Diuretic use 0.94 (0.34 to 1.55) 0.003 0.28 (1.22 to 0.65) 0.54
Cholesterol-lowering medication 0.13 (0.59 to 0.86) 0.71 0.24 (1.19 to 0.69) 0.60
Diabetes mellitus 0.15 (0.92 to 0.63) 0.71 0.64 (0.25 to 1.53) 0.15
Systolic BP (per 10mmHg) 0.16 (0.25 to 0.07) 0.001 0.22 (0.09 to 0.35) 0.002
eGFR
75–89ml/min per 1.73m2 0.08 (0.33 to 0.16) 0.49 0.07 (0.25 to 0.40) 0.65
o75ml/min per 1.73m2 0.52 (1.23 to 0.18) 0.14 0.45 (0.55 to 1.45) 0.37
UACR 4 30mg/g (%) 0.04 (0.42 to 0.35) 0.85 0.10 (0.33 to 0.53) 0.65
Serum albumin (g/dl) 0.33 (1.01 to 0.35) 0.33 0.50 (1.31 to 0.32) 0.22
Serum sodium (mg/dl) 0.44 (0.36 to 0.52) o0.001 —
Serum chloride (mg/dl) 0.33 (0.42 to 0.24) o0.001 —
Serum potassium (mg/dl) 0.32 (0.09 to 0.73) 0.12 0.38 (1.00 to 0.24) 0.22
Serum calcium (mg/dl) 0.20 (0.38 to 0.77) 0.50 0.08 (0.62 to 0.79) 0.81
Serum phosphate (mg/dl) 0.34 (0.50 to 0.18) o0.001 0.52 (0.26 to 0.77) o0.001
Hemoglobin (g/dl) 0.25 (0.39 to 0.10) 0.001 0.31 (0.11 to 0.52) 0.003
Total cholesterol (per 10mg/dl) 0.004 (0.03 to 0.02) 0.71 0.04 (0.01 to 0.07) 0.01
HDL cholesterol (per 10mg/dl) 0.08 (0.02 to 0.17) 0.10 0.04 (0.14 to 0.07) 0.49
CRP
0.14–0.99mg/dl 0.06 (0.25 to 0.14) 0.57 0.29 (0.05 to 0.54) 0.02
X1.0mg/dl 0.18 (0.61 to 0.24) 0.39 0.73 (0.11 to 1.35) 0.02
Abbreviations: BP, blood pressure; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; MET, metabolic equivalent; NEAP, net
endogenous acid production; UACR, urinary albumin–creatinine ratio.
Multivariable model adjusted for all variables listed in the Table. Reference categories are non-Hispanic White for race/ethnicity; 0 MET-min/week for activity level;
non-smokers for smoking status; fasting length p2 h; no soft drink consumption; eGFR X90ml/min per 1.73m2 for eGFR; and CRP o0.14mg/dl.
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25.1–26.9, and X27 mEq/l, respectively). Higher levels of AG
as quartiles were associated with a greater likelihood of low
fitness after multivariable adjustment.
Effect modification of the associations of serum bicarbo-
nate and AG with cardiorespiratory fitness was examined
in fully adjusted models for the covariates specified above.
For all interactions, the P-value was greater than 0.2, except
for serum bicarbonate with sex (P¼ 0.20), activity level
(P¼ 0.003), and CRP (P¼ 0.17). Visual inspection of the
forest plot (Figure 2) demonstrates a similar but inverse
pattern for the associations of serum bicarbonate and AG
within participant subgroups.
Sensitivity analyses. Adjustment for %LBM rendered
associations of serum bicarbonate with fitness nonsigni-
ficant, whereas associations of AG with fitness were mildly
attenuated but remained significant (Table 5). Forty partici-
pants had serum bicarbonate o20 mEq/l. There was a trend
toward greater fitness with higher serum bicarbonate even
among those with low to low-normal bicarbonate levels
(Supplementary Table S1 online, upper panels). Compared
with participants with serum bicarbonate 422 mEq/l, those
with bicarbonate p22 mEq/l had 1.77 (95% CI 0.52–3.01)
ml/kg/min lower estimated VO2max and a greater likelihood
of low fitness (odds ratio 1.73, 95% CI 1.26–2.37) in
multivariable analyses. The association of serum bicarbonate
with estimated VO2max was more robust among men than
among women, but the association with low fitness did not
differ significantly by sex (Supplementary Table S2 online;
P-value for interaction¼ 0.05 and 0.20, respectively). After
calculating AG without adjustment for albumin, we found
no substantive difference in our results (Supplementary
Table S1 online, lower panels). Among participants who
reported never being told of a diagnosis of asthma
(n¼ 2505), the multivariable-adjusted odds ratio for low
fitness was 0.82 (95% CI 0.72–0.94) per s.d. higher serum
bicarbonate and 1.28 (95% CI 1.12–1.46) per s.d. higher AG.
After defining the cohort without exclusions for missing
covariate data or invalid dietary data (n¼ 3013), the age-,
sex-, and race/ethnicity-adjusted odds ratio for low fitness
was 0.84 (95% CI 0.75–0.94) per s.d. higher serum
bicarbonate and 1.30 (95% CI 1.14–1.49) per s.d. higher
AG. Associations with estimated VO2max were also un-
changed (data not shown). There was a direct association of
higher activity decile with greater estimated VO2max and
lower odds of low fitness in unadjusted models (Po0.001 for
trend for each). Including activity deciles in multivariable
models instead of the previously defined categories did not
change the associations of serum bicarbonate and AG with
estimated VO2max or low fitness (data not shown).
DISCUSSION
Our results show that lower levels of serum bicarbonate and
higher levels of AG are associated with low cardiorespiratory
fitness in adults aged 20–49 years in the general US popu-
lation. To our knowledge, this is the first study to examine
these associations on a population-wide level. Furthermore,
the cohort examined in our study was composed of relatively
young, healthy people. These results are of potential public
health importance, given the association of low fitness with
known CVD risk factors11 and with greater risk of all-cause
mortality and CVD events among healthy persons.13
Although oxygen consumption during exercise is deter-
mined by a number of factors, changes in skeletal muscle are
an important contributor to submaximal endurance perfor-
mance.14 For example, an increase in VO2max has been seen
with strength training, possibly because of the adaptations in
oxidative capacity and increased mass of the strength-trained
muscles.15 The association of lower serum bicarbonate with
low fitness may be related to an effect of chronic metabolic
acidosis on skeletal muscle. Acidosis impairs signaling by
insulin and insulin-like growth factor-1 in muscle and stimu-
lates skeletal muscle proteolysis through several mechanisms,
including activation of the ubiquitin–proteasome pathway.16
Metabolic acidosis may also reduce muscle protein synth-
esis.17–19 Alkali administration has produced improvements
in short-term endurance performance and lactate thresh-
old.20,21 Both reduced muscle mass, because of increased
protein breakdown relative to synthesis, and impaired skeletal
muscle function could reduce skeletal muscle oxygen uptake,
thereby resulting in lower VO2max. Therefore, differences
in estimated VO2max may partly reflect skeletal muscle
0
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Figure 1 |Prevalence of low, moderate, and high cardiorespi-
ratory fitness. Percentage of cardiorespiratory fitness level by
quartiles of serum bicarbonate (a) and serum anion gap (b).
Error bars signify standard errors.
Kidney International (2012) 81, 1033–1042 1037
MK Abramowitz et al.: Bicarbonate, anion gap, and fitness o r ig ina l a r t i c l e
adaptations, and acidosis may be associated with fitness
through an effect on muscle. This hypothesis is supported by
the disappearance of an association of serum bicarbonate
with fitness after adjustment for %LBM, which suggests that
LBM may be a mediator of the association of acidosis with
fitness. Although there was a suggestion that the association
of serum bicarbonate with fitness differs among men and
women, this finding should be regarded with caution, given
the differential exclusion of men and women, namely the
exclusion of otherwise eligible pregnant women from
participation (n¼ 595).
These associations can also partly be explained as the
inverse of an effect related to higher levels of AG. The pattern
of associations within subgroups for serum bicarbonate
appears to be a mirror image of the pattern for AG,
suggesting a prominent role for changes in AG in our
findings. Previous cross-sectional studies have shown an
association of higher levels of serum bicarbonate and lower
levels of AG with increased insulin resistance and systolic
blood pressure in the general population.8,10 The etiology for
higher AG in such individuals remains unclear. Higher levels
of endogenous organic acids are one possible explanation.
Animal and human data suggest an association between salt-
sensitive hypertension and lower blood pH and bicarbo-
nate,22–24 which might result from greater endogenous acid
production. Higher lactate levels have been associated with
type 2 diabetes in older adults.25 In a non-diabetic cohort,
a-hydroxybutyrate and other organic acids were inversely
Table 4 | Association of cardiorespiratory fitness with serum bicarbonate and anion gap
Association of estimated VO2max (ml/kg/min) with serum bicarbonate and anion gap
Coefficient (95% CI)
Model 1 Model 2 Model 3
Bicarbonate
Continuousa 1.46 (1.00 to 1.93) 0.65 (0.24 to 1.05) 0.88 (0.44 to 1.31)
o24mEq/l (Ref) (Ref) (Ref)
24–25mEq/l 0.73 (0.53 to 1.99) 0.03 (1.32 to 1.25) 0.18 (1.08 to 1.44)
25.1–26.9mEq/l 2.72 (1.52 to 3.91) 1.41 (0.13 to 2.69) 1.70 (0.41 to 2.98)
X27mEq/l 3.76 (2.17 to 5.35) 1.49 (0.07 to 2.90) 1.85 (0.38 to 3.32)
P for trend o0.001 0.008 0.002
Anion gap
Continuousa 1.07 (1.56 to 0.58) 1.05 (1.49 to 0.61) 0.97 (1.42 to 0.52)
o8.60mEq/l (Ref) (Ref) (Ref)
8.60–10.25mEq/l 1.54 (2.81 to 0.27) 1.19 (2.35 to 0.03) 1.04 (2.08 to 0.01)
10.26–11.90mEq/l 2.41 (3.63 to 1.20) 2.08 (3.13 to 1.03) 1.90 (2.80 to 0.99)
X11.91mEq/l 2.77 (3.91 to 1.63) 2.50 (3.67 to 1.33) 2.24 (3.44 to 1.04)
P for trend o0.001 o0.001 o0.001
Odds ratio of low cardiorespiratory fitness by serum bicarbonate and anion gap
OR (95% CI)
Model 1 Model 2 Model 3
Bicarbonate
Continuousa 0.84 (0.74–0.95) 0.85 (0.75–0.96) 0.80 (0.70–0.92)
o24mEq/l (Ref) (Ref) (Ref)
24–25mEq/l 0.64 (0.43–0.94) 0.64 (0.43–0.95) 0.62 (0.39–0.99)
25.1–26.9mEq/l 0.73 (0.49–1.08) 0.73 (0.49–1.08) 0.69 (0.44–1.08)
X27mEq/l 0.65 (0.41–1.03) 0.68 (0.42–1.09) 0.64 (0.37–1.10)
P for trend 0.07 0.10 0.11
Anion gap
Continuousa 1.32 (1.16–1.51) 1.32 (1.15–1.52) 1.30 (1.15–1.48)
o8.60mEq/l (Ref) (Ref) (Ref)
8.60–10.25mEq/l 1.88 (1.28–2.77) 1.79 (1.21–2.65) 1.74 (1.15–2.62)
10.26–11.90mEq/l 1.69 (1.19–2.41) 1.67 (1.16–2.38) 1.62 (1.16–2.26)
X11.91mEq/l 2.54 (1.78–3.62) 2.48 (1.73–3.55) 2.33 (1.68–3.22)
P for trend o0.001 o0.001 o0.001
Abbreviations: BMI, body mass index; CI, confidence interval; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; OR, odds ratio.
aPer s.d. higher serum bicarbonate (s.d.=2.16mEq/l) and adjusted anion gap (s.d.=2.36mEq/l), respectively.
Bold values indicate Po0.05.
Model 1: unadjusted.
Model 2: adjusted for age, sex, and race/ethnicity.
Model 3: model 2 + adjusted for BMI, poverty, education, activity level, smoking status, estimated dietary potential renal acid load, fasting time, soft drink consumption,
diuretic use, use of cholesterol-lowering medications, diagnosis of diabetes mellitus, systolic blood pressure, eGFR, log-transformed urine albumin–creatinine ratio, serum
albumin, potassium, calcium, phosphate, hemoglobin, total cholesterol, HDL cholesterol, log-transformed CRP, and (for bicarbonate models) serum sodium and chloride.
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associated with insulin sensitivity.26 Thus, a higher AG may
be a marker for factors related to obesity and the metabolic
syndrome even in this relatively healthy cohort.
Increased organic anion production may also account for
the association of soft drink consumption with higher AG
and lower serum bicarbonate. Ingestion of fructose, found
in sugar-sweetened beverages, causes an increase in plasma
lactate.27 This is in accord with the higher AG seen in
association with sugar sweetened, compared with diet, soft
drink consumption in our analysis. However, there was still a
trend toward higher AG in association with diet soft drink
intake. In addition, the majority of blood samples in our
cohort were collected after prolonged fasting. The presence of
a higher lactate level hours after soft drink consumption seems
unlikely, especially in individuals believed to be largely free
of significant liver disease. Soft drink consumption could be
a marker for an unhealthy lifestyle, and such individuals
could have higher lactate levels.25 The phosphoric acid in
soft drinks may partly explain our findings. Although the
participants had largely well-preserved kidney function, a
reduction in urinary phosphate excretion may occur with
relatively preserved kidney function.28 Retained phosphoric
acid could then contribute to the AG. Despite the association
of soft drink consumption with serum bicarbonate and AG
levels, it does not appear to mediate the associations with low
fitness. Our results were independent of the quantity of soft
drink consumption, and the associations with low fitness
were not stronger among consumers of soft drinks.
Age (years)
Serum bicarbonate Serum anion gap
< 35 (n=1461)
< 500 (n=911)
>30 (n=731)
> 0.14 (n=1351)
0
25–30 (n=931)
1 (n=1371)
90 (n=2222)
<90 (n=492)
0.14 (n=1363)
500 (n=1803)
0 (n=1343)
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35 (n=1253)
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Men (n=1460)
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< 25 (n=1052)
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eGFR (ml/min per 1.73 m2)
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Activity level (MET-min/week)
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Odds ratio, with 95% CI
2
Figure 2 | Fully adjusted odds ratios for low cardiorespiratory
fitness within participant subgroups. The P-value was greater
than 0.2 for all interactions, except for effect modification of
serum bicarbonate with sex (P¼ 0.20), activity level (P¼ 0.003),
and C-reactive protein (P¼ 0.17). CI, confidence interval; eGFR,
estimated glomerular filtration rate; MET, metabolic equivalent.
Table 5 | Association of cardiorespiratory fitness with serum bicarbonate and anion gap after adjustment for % lean body mass
Association of estimated VO2max (ml/kg/min) with serum bicarbonate and anion gap
Coefficient (95% CI) Coefficient (95% CI)
Bicarbonate Anion gap
Continuousa 0.14 (0.23 to 0.51) Continuousa 0.68 (1.11 to 0.25)
o24mEq/l (Ref) o8.60mEq/l (Ref)
24–25mEq/l 0.58 (1.93 to 0.76) 8.60–10.25mEq/l 0.83 (2.00 to 0.34)
25.1–26.9mEq/l 0.45 (0.74 to 1.64) 10.26–11.90mEq/l 1.65 (2.67 to 0.64)
X27mEq/l 0.02 (1.26 to 1.31) X11.91mEq/l 1.51 (2.64 to 0.37)
P for trend 0.57 P for trend 0.007
Odds ratio of low cardiorespiratory fitness by serum bicarbonate and anion gap
OR (95% CI) OR (95% CI)
Bicarbonate Anion gap
Continuousa 0.97 (0.86–1.09) Continuousa 1.19 (1.03–1.37)
o24mEq/l (Ref) o8.60mEq/l (Ref)
24–25mEq/l 0.71 (0.47–1.10) 8.60–10.25mEq/l 1.69 (1.09–2.64)
25.1–26.9mEq/l 0.96 (0.63–1.45) 10.26–11.90mEq/l 1.51 (1.05–2.15)
X27mEq/l 0.98 (0.63–1.54) X11.91mEq/l 1.96 (1.31–2.93)
P for trend 0.98 P for trend 0.005
Abbreviations: CI, confidence interval; OR, odds ratio.
aPer s.d. higher serum bicarbonate (s.d.=2.16mEq/l) and adjusted anion gap (s.d.=2.36mEq/l), respectively.
Bold values indicate Po0.05.
Models adjusted for age, sex, race/ethnicity, and % lean body mass.
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Higher dietary acid load has been associated with the
development of hypertension29 and can cause low-grade
metabolic acidosis.30 However, we did not find an indepen-
dent association of NEAP with bicarbonate levels and our
analyses were adjusted for NEAP. Nevertheless, we may have
been unable to fully account for dietary factors because of
imprecision in the collection of dietary data and in the
estimation of NEAP.
VO2max was estimated in our cohort as direct measure-
ments were not feasible in a large epidemiological study.
The estimation of VO2max using heart rate changes may
vary from directly measured VO2max by up to 10–20%.
31
Nevertheless, it is believed to provide a satisfactory estimate
for studies such as ours that are conducted on a group level.31
Estimated VO2max determined in this manner has been
associated with mortality risk,13 thereby affording it prog-
nostic significance. Furthermore, inaccuracy in estimation of
VO2max leading to misclassification of participants’ fitness
levels would be expected to bias our results toward the null
hypothesis. Thus, we believe our findings are robust despite
this potential inaccuracy.
Several important limitations of our analysis should
be noted. As levels of arterial pH and pCO2 were unavailable,
we cannot exclude lower bicarbonate levels as a marker of
alterations in respiratory status. However, participants with
chronic obstructive pulmonary disease or respiratory symp-
toms were not included in our analysis, and excluding
those with a diagnosis of asthma did not change our results.
Levels of serum bicarbonate and AG were determined from
single measurements, and variability in sample handling
may affect bicarbonate levels.32–34 We could not account for
this possibility, which would be expected to introduce
non-differential misclassification and likely bias our results
toward the null hypothesis. Analyses of NEAP may have
been affected by the limitations of dietary assessment using
a single 24-h recall period. Given the associations of serum
bicarbonate and AG with BMI and other markers of the
metabolic syndrome, there may be residual confounding
related to sedentary lifestyle. Objective measures of physical
activity would have added additional information but were
unavailable for this cohort. However, physical activity was
assessed by detailed questionnaires and did provide mean-
ingful quantitative information, as demonstrated by the
expected association with cardiorespiratory fitness, suggest-
ing that our findings were not simply because of imprecise
quantification of physical activity. Finally, no causal asso-
ciations can be inferred because of the cross-sectional nature
of our analysis, and we are unable to exclude the possibility
of reverse causality. For example, low fitness, if associated
with chronic disease, could cause low serum bicarbonate,
either from respiratory alkalosis because of occult liver
or cardiopulmonary disease or from impaired renal acid
excretion. However, given the age and health status of the
participants in the treadmill test protocol, a substantial
burden of chronic illness seems unlikely. Similarly, predictors
of serum bicarbonate and AG might be different among older
persons or those with chronic illness than among our
participants.
In summary, we have shown that lower levels of serum
bicarbonate and higher levels of AG are associated with
lower cardiorespiratory fitness in adults aged 20–49 years
in the general US population. Further studies are needed to
elucidate the determinants of serum bicarbonate and AG in
persons without overt kidney disease and to prospectively
examine associations of serum bicarbonate and AG with
fitness and other CVD risk factors.
MATERIALS AND METHODS
Study population
NHANES 1999–2004 was a nationally representative survey of the
non-institutionalized civilian population in the United States.35 A
stratified, multistage, probability sampling design was used to select
participants. Overall, 3302 adults aged 20–49 years completed the
interview and examination components, including the cardiovas-
cular fitness component. We excluded participants with missing data
on serum bicarbonate (n¼ 137); a history of emphysema or chronic
bronchitis by self-report (n¼ 101); who were pregnant at the time of
examination (n¼ 51); had invalid dietary data (n¼ 74); or had
missing covariate data (n¼ 225). No participants had an estimated
glomerular filtration rate (eGFR)o15 ml/min per 1.73 m2, and four
had eGFRo60 ml/min per 1.73 m2. Thus, 2714 participants were
available for analysis. The Committee on Clinical Investigation at
the Albert Einstein College of Medicine determined this analysis to
be exempt.
Data collection
Information on household income, education, physical activity,
smoking, comorbidities, and medication use in the previous month
was obtained by self-report. Race/ethnicity was self-identified.
Poverty was defined as o100% of the poverty index based on
self-reported household income. Participants were asked about the
frequency and duration of walking or bicycling, home or yard work,
and moderate or vigorous leisure-time physical activity performed
within the past 30 days. These responses were used to calculate
metabolic equivalents (MET-min/week) on the basis of intensity
values recommended by the National Center for Health Statistics.36
Activity level was classified as 0, o500, 500–2000, or 42000 MET-
min/week. Smoking was classified as never, former, or current
smoker. Data on dietary intake were obtained from a 24-h dietary
recall questionnaire. The diet-dependent net acid load was estimated
as: NEAP (mEq/day)¼ (54.5 protein (g/day)/potassium (mEq/
day)) –10.2.37 Soft drink consumption was defined using USDA
Food Codes 92400000 through 92411620 and was also categorized as
sugar sweetened or diet. Hypertension was defined as a systolic
blood pressure X140 mmHg, diastolic blood pressure X90 mmHg,
physician diagnosis, and/or antihypertensive medication use.38
A participant was considered to have diabetes mellitus if he or she
reported a physician diagnosis while not pregnant or the current use
of insulin or oral hypoglycemic medications, or had a glycohemo-
globin level X6.5%.
Serum chemistry values were measured using the Hitachi 917
multichannel analyzer (Roche Diagnostics, Indianapolis, IN) from
1999 to 2001 and the Beckman Synchron LX20 (Beckman Coulter,
Brea, CA) from 2002 to 2004. Serum bicarbonate was measured in
two laboratories via the phosphoenolpyruvate carboxylase method
from 1999 to 2001 and with a pH-sensitive electrode from 2002 to
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2004. The coefficient of variation ranged between 2.3 and 5.6%.
Serum bicarbonate levels during these time periods were compared
using weighted linear regression. Mean serum bicarbonate was
1.105±0.178 mEq/l higher (Po0.001) among all NHANES parti-
cipants from 2003 to 2004 compared with participants from 1999 to
2002. Therefore, serum bicarbonate levels from 1999 to 2002 were
adjusted by adding 1.105 mEq/l. AG was defined as: AG(initial)¼
serum sodium(mEq/l)–(serum chloride(mEq/l)þ serum bicarbona-
te(mEq/l)), and was adjusted for serum albumin using the following
equation: AG¼AG(initial)þ 2.5 (4–serum albumin(g/dl)).39 Serum
creatinine was measured by a modified kinetic Jaffe´ reaction. Values
from 1999 to 2000 were calibrated to the Cleveland Clinic laboratory
standard by multiplying by 1.013 and then adding 0.147. Correction
of serum creatinine values from 2001 to 2004 was not necessary.
eGFR was calculated using the Chronic Kidney Disease Epidemiol-
ogy Collaboration (CKD-EPI) equation.40 As ingestion of food may
affect serum bicarbonate levels,41 the period of fasting before
phlebotomy was categorized as p2, 2–6, and 46 h. Body composi-
tion was assessed using whole-body dual-energy X-ray absorptio-
metry. Owing to the pattern of non-response, missing and invalid
data were multiply imputed. Details of the dual-energy X-ray
absorptiometry protocol, quality control analyses, and the multiple
imputation procedure are available (http://www.cdc.gov/nchs/
nhanes/dxx/dxa.htm). The %LBM was calculated as 100 total
body lean mass (excluding bone mineral content)/total mass.
Repeating the calculation using total body lean mass (including
bone mineral content) did not change the results.
Outcome variables
The cardiovascular fitness component consisted of a submaximal
exercise test in individuals aged 12–49 years. Participants were
excluded from participation on the basis of physical limitations,
cardiovascular conditions and symptoms, asthma symptoms, lung/
breathing conditions and symptoms, and medications including
beta-blockers and calcium-channel blockers. The initial goal of the
protocol was to elicit a heart rate that is 75% of the age-predicted
maximum and was later modified to allow heart rates of 80% of the
age-predicted maximum among adults. Participants were assigned
to one of eight treadmill test protocols of varying difficulty on the
basis of age, sex, BMI, and self-reported level of physical activity.
Maximal oxygen consumption (VO2max, ml/kg/min) was estimated
from the heart rate response to reference workloads. Higher
VO2max indicates better cardiorespiratory fitness. In addition, as
recommended in the NHANES Cardiovascular Fitness Procedure
Manual, participants were categorized as having low (o20th percentile),
moderate (20th–59th percentile), or high (X60th percentile) fitness
based on age- and sex-specific cut points derived from the Aerobics
Center Longitudinal Study.42,43 Details of the protocols and
formulas used are available in the Procedure Manual at http://
www.cdc.gov/nchs/data/nhanes/nhanes_03_04/cv_99-04.pdf. We
specifically examined low fitness as an outcome because submaximal
exercise testing may not be ideal for determining high fitness as it
may understress fit individuals.43
Statistical analysis
All analyses used NHANES appropriate sampling weights and
accounted for the complex multistage cluster design using the ‘survey’
command in Stata 11.1 (Stata, College Station, TX). The distribu-
tions of participant characteristics were examined by quartiles
of serum bicarbonate and AG. Multivariable linear regression
models were used to determine independent predictors of serum
bicarbonate and AG, separately. Linear and logistic regression
models were created to examine separately the associations of serum
bicarbonate and AG with estimated VO2max and low cardiore-
spiratory fitness, respectively. Serum bicarbonate and AG were
analyzed as continuous variables and within quartiles to examine
non-linear associations with either outcome. A variable was
included in the final model based on association with the predictor
(bicarbonate or AG) and the outcome (Po0.20) and on a priori
determination of confounders of the association of serum bicar-
bonate or AG with cardiorespiratory fitness. These included known
determinants of cardiovascular health and fitness and factors that
may affect levels of serum bicarbonate or AG, including relevant
laboratory parameters. Variables included in the final models were
age, sex, race/ethnicity, BMI, poverty, education, activity level,
smoking status, estimated NEAP, fasting length, soft drink
consumption, diuretic use, use of cholesterol-lowering medica-
tions, diagnosis of diabetes mellitus, systolic blood pressure,
eGFR categories, log-transformed urine albumin-to-creatinine
ratio, serum albumin, potassium, total calcium (not adjusted for
albumin), phosphate, hemoglobin, total cholesterol, high-density
lipoprotein cholesterol, log-transformed CRP, and (for bicarbonate
models) serum sodium and chloride. Effect modification by age,
sex, race/ethnicity, BMI, activity level, soft drink consumption,
eGFR, and CRP was tested by including multiplicative interaction
terms in the models. A P-value o0.05 was considered statistically
significant.
All analyses were repeated using unadjusted serum bicarbonate
values from 1999 to 2002, and also using survey year–specific
quartiles of serum bicarbonate and AG. As the results were not
materially different, only those using the adjusted serum bicarbonate
values from 1999 to 2002 are presented.
Sensitivity analyses. Possible mediation by muscle mass of the
associations with fitness was assessed by adding %LBM as a covariate
to age-, sex-, and race/ethnicity-adjusted models. We explored the
impact of severity of acidosis by subcategorizing participants in the
lowest quartile of serum bicarbonate. We also examined associations
of serum bicarbonate with fitness using the clinical cut point of
serum bicarbonatep22 mEq/l. As serum bicarbonate differed signi-
ficantly by sex, we examined the association of serum bicarbonate
with fitness in fully adjusted, sex-stratified models. We calculated
AG without adjustment for serum albumin and repeated our analyses
to determine whether our findings were a result of differences in
albumin level and not the AG per se. Although participants were
excluded from the cardiovascular fitness component on the basis of
respiratory symptoms, some reported a diagnosis of asthma. As
differences in serum bicarbonate could be due to respiratory factors,
we repeated our analyses after excluding participants who answered
yes to the question, ‘Has a doctor or other health professional ever
told you that you have asthma?’ To determine whether our findings
resulted from excluding participants with missing covariate data or
invalid dietary data, we redefined the cohort without these
exclusions and calculated age-, sex-, and race/ethnicity-adjusted
estimates. Finally, to examine the possibility of residual confound-
ing because of our categorization of activity level, we created
deciles of activity on the basis of MET-min/week and reexamined
the fully adjusted models.
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